SCHEMBL21166567

SCHEMBL21166567

Cc1nc2cc3sc4cc5nc(C)sc5cc4c3cc2s1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.68
NPC1 O15118 4/20 0.68
RAB9A P51151 4/20 0.68
ALDH1A1 P00352 3/20 0.68
HSD17B10 Q99714 2/20 0.68
TP53 P04637 2/20 0.68
MAPT P10636 1/20 0.68
PKM P14618 1/20 0.68
HPGD P15428 1/20 0.68
GAA P10253 2/20 0.63
ALOX15 P16050 1/20 0.46
ATM Q13315 1/20 0.46
CHRNB2 P17787 1/20 0.45
CHRNA4 P43681 1/20 0.45
TDP1 Q9NUW8 2/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 2/20 0.41
LDHA P00338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21166586 0.91 SMN1; SMN2 (0.75) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL4384430 0.89 SMN1; SMN2 (0.85) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL21166649 0.82 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL12635465 0.81 SMN1; SMN2 (1.00) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL18177599 0.81 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL30422583 0.77 GAA (1.00) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL33272 0.77 GAA (1.00) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL19757341 0.77 SMN1; SMN2 (0.72) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL19250836 0.77 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
Bromide SCHEMBL10995945 0.76 GAA (0.95) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10985327-B2 Microcrystalline organic semiconductor film, organic semiconductor transistor, and method of manufacturing organic semiconductor transistor FUJIFILM CORPORATION (JP) 2021-04-20 US disclosed
US-20190237677-A1 MICROCRYSTALLINE ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR TRANSISTOR, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR TRANSISTOR FUJIFILM CORPORATION (JP) 2019-08-01 US disclosed
US-20190221754-A1 BOTTOM GATE TYPE ORGANIC SEMICONDUCTOR TRANSISTOR FUJIFILM CORPORATION (JP) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190237677-A1 MICROCRYSTALLINE ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR TRANSISTOR, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR TRANSISTOR OR10J3, ALK, MSMO1 SMN1; SMN2 3981/4885NPC1 2154/4885RAB9A 1473/4885
US-10985327-B2 Microcrystalline organic semiconductor film, organic semiconductor transistor, and method of manufacturing organic semiconductor transistor OR10J3, ALK, MSMO1 SMN1; SMN2 3981/4885NPC1 2154/4885RAB9A 1473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.